Velescu A, Clarà A, Peñafiel J, Ramos R, Martí R, Grau M, Dégano IR, Marrugat J, Elosua R
Atherosclerosis. 2015 Aug;241(2):357-63, PMID: 26071658
Cardiovascular risk estimation is a key element of current primary prevention strategies, despite its limited accuracy. Several biomarkers are being tested to assess their capacity to improve coronary (CHD) and cardiovascular (CVD) prediction. One of these biomarkers is ankle brachial index (ABI). The aim of this study was to assess whether the inclusion of ABI improved the predictive capacity of the Framingham-REGICOR risk function in an area of low CVD incidence.
PERIPHERAL VASCULAR DISEASE